SMTL ID : 8g3c.1

Crystal structure of human WDR5 in complex with N-[(2'-cyano[1,1'-biphenyl]-4-yl)methyl]-3-hydroxy-6-methyl-4-oxo-4H-pyran-2-carboxamide (compound 1, WDR5-MYC PPI inhibitor)

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 1.80 Å

Oligo State

monomer

Ligands

1 x YJN: N-[(2'-cyano[1,1'-biphenyl]-4-yl)methyl]-3-hydroxy-6-methyl-4-oxo-4H-pyran-2-carboxamide(Non-covalent)

YJN.1: 10 residues within 4Å: Chain A: R.160, S.202, P.203, N.204, Y.207, F.245, V.247, K.251, L.267, Q.268 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:Y.207, A:Y.207, A:L.267 Hydrogen bonds: A:N.204, A:N.204, A:K.251 Water bridges: A:K.251, A:K.251

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ding, J. et al., Discovery and Structure-Based Design of Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)-MYC Interaction. J.Med.Chem. (2023)

Release Date

2023-06-28

Peptides

WD repeat-containing protein 5: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

WD repeat-containing protein 5

Related Entries With Identical Sequence